Spencer, A., Samoilova, O., Chng, W., Labotka, R., Li, C., Wu, K., . . . SINGAPORE, C. S. I. O. (2023). Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial. Wiley.
Chicago Style CitationSpencer, Andrew, et al. Impact of Ixazomib-lenalidomide-dexamethasone Therapy On Overall Survival in Multiple Myeloma Patients: Analysis of the Emerging-markets Subgroup of the TOURMALINE-MM1 Trial. Wiley, 2023.
MLA CitationSpencer, Andrew, et al. Impact of Ixazomib-lenalidomide-dexamethasone Therapy On Overall Survival in Multiple Myeloma Patients: Analysis of the Emerging-markets Subgroup of the TOURMALINE-MM1 Trial. Wiley, 2023.
Warning: These citations may not always be 100% accurate.